Qube Research & Technologies (QRT)
ARMP icon

Qube Research & Technologies (QRT)’s Armata Pharmaceuticals ARMP Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-26,628
Closed -$273K – 3450
2026
Q1 		$273K Buy
26,628
+3,272
+14% +$27.5K ﹤0.01% 2887
2025
Q4 		$147K Buy
+23,356
New +$128K ﹤0.01% 3121
2024
Q3 		– Sell
-1,908
Closed -$5.25K – 3284
2024
Q2 		$5.25K Sell
1,908
-20,506
-91% -$58.5K ﹤0.01% 3035
2024
Q1 		$93.7K Sell
22,414
-1,149
-5% -$4.16K ﹤0.01% 3324
2023
Q4 		$76.3K Buy
23,563
+21,372
+975% +$50.5K ﹤0.01% 3184
2023
Q3 		$6.57K Buy
+2,191
New +$5.88K ﹤0.01% 3400

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ARMP Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Armata Pharmaceuticals (ARMP) in Q2 2026, closing a stake of 26,628 shares — an estimated $273K sold.

Qube Research & Technologies (QRT) first reported a position in ARMP in Q3 2023 and held it in 6 quarters. The position peaked at $273K in Q1 2026. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Armata Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 26,628 Armata Pharmaceuticals shares in Q2 2026, an estimated $273K.
  • Qube Research & Technologies (QRT) first reported a position in Armata Pharmaceuticals in Q3 2023 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s Armata Pharmaceuticals position peaked at $273K in Q1 2026.
  • 53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.